Skip to content

IL-33/ ST2 pathway regulating ILC2 mediated eosinophilic COPD phenotype

IL-33/ ST2 pathway regulating ILC2 mediated eosinophilic COPD phenotype

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022053
Enrollment
Unknown
Registered
2019-03-22
Start date
2019-03-25
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

eosinophilic COPD, Eos-COPD:No intervention
Noneos-COPD:No intervention
Healthy control group:No intervention

Sponsors

Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) patients meets the diagnostic criteria of COPD and are in a stable period; 2) aged 45-80 years; 3) sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) patients with bronchial asthma or bronchial asthma-copd overlap syndrome; 2) bronchiectasis, pulmonary interstitial fibrosis and other chronic respiratory diseases; 3) complicated with serious cardiovascular diseases, liver, kidney, blood and other primary diseases of the system; 4) combined with malignant tumor; 5) other diseases affecting eosinophils, such as allergic dermatitis, allergic rhinitis, eosinophilic gastroenteritis, and primary eosinophilia; 6) failing to cooperate with relevant inspection.

Design outcomes

Primary

MeasureTime frame
ILC2 ratio of peripheral blood;The levels of Il-33 in the peripheral blood;The expressions of ST2 in the peripheral blood;The expressions of GATA3 in the peripheral blood;The expressions of phosphorylated NF-?B p65 in the peripheral blood;

Countries

China

Contacts

Public ContactWei Liu

West China School of Medicine, Sichuan University

576595275@qq.com+86 18583678610

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026